Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin-6 is elevated in plasma in multiple sclerosis.

K Frei1, S Fredrikson, A Fontana

  • 1Section of Clinical Immunology, University Hospital, Zürich, Switzerland.

Journal of Neuroimmunology
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Abstracts of the 6th FECS Conference 1998 Lectures.

Environmental science and pollution research international·2008
Same author

Temporally controlled modulation of antihydrogen production and the temperature scaling of antiproton-positron recombination.

Physical review letters·2008
Same author

Neutron scattering study of the vibrations in vitreous silica and germania.

The Journal of chemical physics·2008
Same author

Damping of sound waves in the terahertz range and strength of the boson peak.

The Journal of chemical physics·2008
Same author

Phase II study of sequential chemotherapy with docetaxel-estramustine followed by mitoxantrone-prednisone in patients with advanced hormone-refractory prostate cancer.

British journal of cancer·2007
Same author

[Early infantile and late infantile form of Krabbe disease: CT and MRI findings].

La Pediatria medica e chirurgica : Medical and surgical pediatrics·2007

Interleukin-6 (IL-6) levels were higher in the plasma of multiple sclerosis (MS) patients compared to other conditions. This suggests a potential systemic B cell response in MS, though its significance remains unclear.

Area of Science:

  • Neuroimmunology
  • Cytokine Research

Background:

  • Interleukin-6 (IL-6) is a cytokine crucial for B cell immunoglobulin production.
  • Elevated IL-6 levels are implicated in various inflammatory and neurological conditions.

Purpose of the Study:

  • To measure and compare IL-6 levels in cerebrospinal fluid (CSF) and plasma of patients with multiple sclerosis (MS), acute meningo-encephalitis (AM), and tension headache (TH).
  • To investigate the relationship between IL-6 levels and disease activity in MS.
  • To explore the potential role of IL-6 in the pathophysiology of MS.

Main Methods:

  • Quantification of IL-6 concentrations in both CSF and plasma samples.
  • Comparative analysis of IL-6 levels across patient groups (MS, AM, TH).
  • Longitudinal sampling in MS patients to assess disease activity correlation.

Related Experiment Videos

Main Results:

  • MS patients exhibited significantly higher plasma IL-6 levels compared to AM and TH patients.
  • In MS, plasma IL-6 was approximately 17 times higher than CSF IL-6.
  • In AM, CSF IL-6 was 20-fold higher than plasma IL-6 during the acute phase, decreasing with recovery.
  • No correlation was found between IL-6 levels (plasma or CSF) and MS disease activity.

Conclusions:

  • Elevated plasma IL-6 in MS patients supports the hypothesis of a systemic B cell response.
  • The functional significance of increased IL-6 in MS plasma requires further investigation.
  • Distinct IL-6 distribution patterns were observed between MS and AM, highlighting condition-specific cytokine involvement.